Mitophagy-Mediated Cell Death in Mammary Tumorigenesis

乳腺肿瘤发生中线粒体自噬介导的细胞死亡

基本信息

  • 批准号:
    10470906
  • 负责人:
  • 金额:
    $ 39.06万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-01 至 2026-08-31
  • 项目状态:
    未结题

项目摘要

Project Summary Background: The metastasis of cancerous cells to distant and vital organs is responsible for in excess of 90% of cancer mortalities. Given this extraordinarily high mortality rate, there is a significant need for the development of novel therapeutic approaches that either eliminate metastatic cancer cells or eradicate incipient cancer cells prior to metastatic dissemination. An important barrier to tumor progression and metastasis is anoikis, a caspase- dependent cell death program induced by loss of integrin-mediated attachment to extracellular matrix (ECM). However, it has become clear that ECM-detachment can induce anoikis-independent mechanisms that can compromise cell viability. More specifically, we have discovered that detachment of non-cancerous epithelial cells from ECM triggers a significant elevation in the levels of reactive oxygen species (ROS) which compromises cell survival in an anoikis-independent fashion. The understanding of the cellular changes that contribute to the elevation of ROS during ECM-detachment remains rudimentary and the strategies utilized by cancer cells to combat ROS during ECM-detachment are insufficiently explored. Therefore, these points represent significant knowledge gaps that this grant proposal aims to address. Discernment of mechanistic information regarding the links between ECM-detachment, ROS, and cell survival could provide targets for the design of the therapeutic approaches aimed at specifically eliminating ECM-detached cancer cells; an outcome that may have significant impact for patients with metastatic disease. Objective/hypothesis: In aggregate, our preliminary studies have unveiled a novel cell death mechanism (with a tumor suppressive function) that compromises the viability of ECM-detached cells: the induction of mitophagy as consequence of RIPK1 signaling. As such, these data have motivated our central hypothesis that RIPK1- mediated mitophagy during ECM-detachment functions as a barrier to breast cancer progression. Specific Aim I: To elucidate the molecular mechanism by which ECM-detachment promotes RIPK1-dependent mitophagy and initiates cell death. Specific Aim II: To assess the capacity of RIPK1-mediated mitophagy to antagonize tumor formation in vivo and to evaluate antioxidant inhibition as a novel strategy to limit tumorigenesis in cancers that are deficient in RIPK1-mediated mitophagy Anticipated Outcomes: Following the completion of these studies, we will have accumulated significant mechanistic knowledge regarding the relationship between ECM-detachment, RIPK1 mitophagy, and cell death. Thus, the completion of these studies will unveil fundamental biological insights regarding cancer cell survival during ECM-detachment that may ultimately lead to the development of therapeutic approaches to limit the dissemination of breast cancer cells.
项目摘要 背景:超过90%的癌症是由于癌细胞转移到远处和重要器官所致。 癌症死亡率。鉴于这一极高的死亡率, 消除转移癌细胞或根除初期癌细胞的新治疗方法 在转移扩散之前。肿瘤进展和转移的一个重要屏障是失巢凋亡,一种半胱天冬酶, 由整合素介导的与细胞外基质(ECM)的附着丧失诱导的依赖性细胞死亡程序。 然而,已经清楚的是,ECM脱离可以诱导失巢凋亡独立机制, 损害细胞活力。更具体地说,我们发现非癌上皮细胞的脱落 ECM中的细胞引发活性氧(ROS)水平的显著升高, 细胞存活在一个失巢凋亡独立的方式。对细胞变化的理解有助于 在ECM脱离期间ROS的升高仍然是基本的,癌细胞利用的策略是, ECM脱离期间的战斗ROS没有得到充分的探索。因此,这些点代表了重要的 知识差距,这一赠款提案旨在解决。机械信息识别 ECM脱离、ROS和细胞存活之间的联系可以为治疗药物的设计提供靶点。 旨在特异性消除ECM脱离的癌细胞的方法;这一结果可能具有显著的 对转移性疾病患者的影响。 目的/假设:总的来说,我们的初步研究揭示了一种新的细胞死亡机制( 肿瘤抑制功能),损害ECM-脱离细胞的生存力:诱导线粒体自噬 这是RIPK 1信号传导的结果。因此,这些数据激发了我们的中心假设,即RIPK 1- ECM脱离期间介导的线粒体自噬作为乳腺癌进展的屏障发挥作用。 具体目的I:阐明ECM-脱离促进RIPK 1依赖性 线粒体自噬并引发细胞死亡。 具体目的II:评估RIPK 1介导的线粒体自噬拮抗体内肿瘤形成的能力 并评估抗氧化剂抑制作为一种新的策略,以限制肿瘤发生的癌症是缺乏 RIPK 1介导的线粒体自噬 预期成果:完成这些研究后,我们将积累大量 关于ECM脱离、RIPK 1线粒体自噬和细胞死亡之间关系的机制知识。 因此,这些研究的完成将揭示关于癌细胞的基本生物学见解, ECM分离期间的存活率,最终可能导致治疗方法的发展 来限制乳腺癌细胞的扩散。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Zachary T. Schafer其他文献

Cancer cell survival during detachment from the ECM: multiple barriers to tumour progression
癌细胞在脱离细胞外基质期间的存活:肿瘤进展的多重障碍
  • DOI:
    10.1038/nrc3789
  • 发表时间:
    2014-08-07
  • 期刊:
  • 影响因子:
    66.800
  • 作者:
    Cassandra L. Buchheit;Kelsey J. Weigel;Zachary T. Schafer
  • 通讯作者:
    Zachary T. Schafer
Ancestry-linked stromal variations impact breast epithelial cell invasion
与祖先相关的基质变异影响乳腺上皮细胞侵袭
  • DOI:
    10.1016/j.isci.2025.112686
  • 发表时间:
    2025-06-20
  • 期刊:
  • 影响因子:
    4.100
  • 作者:
    Madison G. Schmidtmann;Victoria Elliott;James W. Clancy;Zachary T. Schafer;Harikrishna Nakshatri;Crislyn D’Souza-Schorey
  • 通讯作者:
    Crislyn D’Souza-Schorey

Zachary T. Schafer的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Zachary T. Schafer', 18)}}的其他基金

Mitophagy-Mediated Cell Death in Mammary Tumorigenesis
乳腺肿瘤发生中线粒体自噬介导的细胞死亡
  • 批准号:
    10277900
  • 财政年份:
    2021
  • 资助金额:
    $ 39.06万
  • 项目类别:
The Role of Metabolic Alterations in Anchorage-Independent Survival
代谢改变在锚地独立生存中的作用
  • 批准号:
    7484234
  • 财政年份:
    2007
  • 资助金额:
    $ 39.06万
  • 项目类别:
The Role of Metabolic Alterations in Anchorage-Independent Survival
代谢改变在锚地独立生存中的作用
  • 批准号:
    7328792
  • 财政年份:
    2007
  • 资助金额:
    $ 39.06万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 39.06万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.06万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 39.06万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.06万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 39.06万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 39.06万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.06万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 39.06万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 39.06万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.06万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了